1. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma
   Cristina Di Giorgio et al, 2023, Frontiers in Oncology CrossRef
2. Elevated expression of LIF predicts a poor prognosis and promotes cell migration and invasion of clear cell renal cell carcinoma
   Wenting Zhong et al, 2022, Frontiers in Oncology CrossRef
3. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma
   Cristina Di Giorgio et al, 2022, Cells CrossRef
4. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness
   William S. Streitfeld et al, 2023, Cancer Biology & Therapy CrossRef
5. Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma
   Bradley R. Hall et al, 2018, Genes & Cancer CrossRef
6. The Quasimesenchymal Pancreatic Ductal Epithelial Cell Line PANC-1—A Useful Model to Study Clonal Heterogeneity and EMT Subtype Shifting
   Hendrik Ungefroren et al, 2022, Cancers CrossRef
7. Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer
   Joe Christianson et al, 2021, Frontiers in Oncology CrossRef
8. Glycosylation Changes in Serum Proteins Identify Patients with Pancreatic Cancer
   Anna Drabik et al, 2017, Journal of Proteome Research CrossRef
9. Leukemia Inhibitory Factor: An Important Cytokine in Pathologies and Cancer
   Megan M. Jorgensen et al, 2022, Biomolecules CrossRef